BeiGene's medical website with resources for healthcare professionals and disease information for patients and caregivers.
Please confirm the option below that best describes you so we can direct you to appropriate resources and information.
This book offers the necessary information for patients diagnosed with Waldenström’s macroglobulinemia (WM) to engage in meaningful conversations with their healthcare providers. It empowers them to make informed decisions about managing their condition. Download this e-book to provide your patients with a deeper understanding of their illness.
A global congress digest on targeted therapies in B-cell malignancies covering updates from recent studies presented at EHA2024.
Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.
Video
Roundtable discussion at the EHA2024 Hybrid Congress focusing on the management of chronic lymphocytic leukemia (CLL) and indolent lymphoma patients under Bruton’s tyrosine kinase inhibitor (BTKi) treatment.
Video
This book provides an overview of the current knowledge on the pathophysiology, epidemiology and etiology of Waldenström’s macroglobulinemia (WM) and discusses how the disease may present, how it is diagnosed and when treatment should be initiated. An outline of current approaches to treatment as well as ongoing and planned research directions is also included. It contains a wealth of information for all members of the multidisciplinary team who care for patients with WM in the fields of hematology, oncology, gerontology, pathology and neurology.
